Earnings-Week Options: Bulls Circle Moderna, Bears Hedge Autos

Options markets are sending mixed signals heading into a heavy auto earnings week. Moderna stands out. The biotech carries an 88% probability of joining the MSCI World index, according to ORTEX's Index Rebalance Radar. That would trigger an estimated $5.9 billion in forced buying from trackers. Its options chain runs expiries all the way out to January 2027, suggesting traders are positioning well beyond the short term.

Uber also has an active options chain through January 2027. Its shares are down 20% year-to-date. Analysts see 54% upside from current levels. The COO just bought $5.3 million of stock in the open market. Options bets skewed net-positive in the past week.

Defensive positioning is visible across industrial REITs and financials, where 100% of the past week's options flow registered as bullish. Micron Technology and Intel drew the heaviest negative bets in the market, consistent with continued pressure on legacy semiconductor names.

On the macro side, the auto earnings queue this week carries real risk. India's new car registrations collapsed 84% year-on-year in October, according to Vahan data. Honda Motor and Polestar both report by 6 November, with leading indicators pointing down. Ferrari, reporting today, faces a reading 75% below last year from Austrian registration data. Put activity on the November expiry for RACE reflects that caution.

SPY expiries running every single trading day through to January 2027 point to elevated hedging demand. Traders are not letting their macro exposure run unprotected into this earnings season.